Safety and tolerability of inhalational anticholinergics in COPD

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality. With the significant toll of the disease, more resources have been invested in developing new treatment modalities. Among these medications, inhalational anticholinergics are widely used for the management of...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharafkhaneh, Amir, Majid, Hashir, Gross, Nicholas J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596125/
https://www.ncbi.nlm.nih.gov/pubmed/23526112
http://dx.doi.org/10.2147/DHPS.S7771

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596125/
https://www.ncbi.nlm.nih.gov/pubmed/23526112
http://dx.doi.org/10.2147/DHPS.S7771

Ejemplares similares